View in EDS HTML Full Text PDF Full Text

PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue.

Saved in:
Bibliographic Details
Title: PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue.
Authors: Lee S; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Yoon SJ; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lim J; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Oh JH; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Ryu JS; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Kim G; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea., Kang H; HITS Inc., Seoul, Republic of Korea., Jo N; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lee S; HITS Inc., Seoul, Republic of Korea., Jang S; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea., Lee Y; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea., Park Y; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea., Hwang ES; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.
Source: Frontiers in pharmacology [Front Pharmacol] 2026 Mar 12; Vol. 17, pp. 1755268. Date of Electronic Publication: 2026 Mar 12 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41908829
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Yoon+SJ%22">Yoon SJ</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lim+J%22">Lim J</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oh+JH%22">Oh JH</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Ryu+JS%22">Ryu JS</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+G%22">Kim G</searchLink>; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+H%22">Kang H</searchLink>; HITS Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jo+N%22">Jo N</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+S%22">Lee S</searchLink>; HITS Inc., Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jang+S%22">Jang S</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+Y%22">Lee Y</searchLink>; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Hwang+ES%22">Hwang ES</searchLink>; College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul, Republic of Korea.; Gradutate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2026 Mar 12; Vol. 17, pp. 1755268. <i>Date of Electronic Publication: </i>2026 Mar 12 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41908829
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2026.1755268
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1755268
    Titles:
      – TitleFull: PoMA-10: a dual-action antiviral disrupting SARS-CoV-2 Spike-ACE2 interaction and protecting lung tissue.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Yoon SJ
      – PersonEntity:
          Name:
            NameFull: Lim J
      – PersonEntity:
          Name:
            NameFull: Oh JH
      – PersonEntity:
          Name:
            NameFull: Ryu JS
      – PersonEntity:
          Name:
            NameFull: Kim G
      – PersonEntity:
          Name:
            NameFull: Kang H
      – PersonEntity:
          Name:
            NameFull: Jo N
      – PersonEntity:
          Name:
            NameFull: Lee S
      – PersonEntity:
          Name:
            NameFull: Jang S
      – PersonEntity:
          Name:
            NameFull: Lee Y
      – PersonEntity:
          Name:
            NameFull: Park Y
      – PersonEntity:
          Name:
            NameFull: Hwang ES
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 03
              Text: 2026 Mar 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1